{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:41:35Z","timestamp":1789004495255,"version":"build-2803163510"},"reference-count":32,"publisher":"Wiley","issue":"S5","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In recent years, new approaches for optimal patient management of cancer have focused on patient\u2010centered care, with integration of tumour\u2010directed treatment and patient\u2010directed supportive and palliative care throughout the disease journey from prevention through screening, diagnosis, treatment, and follow\u2010up. In 2022, at the International Forum of Dermatology (IFD), a scientific session was entirely dedicated to highlight recent developments on patient\u2010centered approaches in skin cancer. An international panel of different groups of participants involved in a patient's journey on the management of skin cancer presented and discussed challenges and barriers that persist in the field of skin cancer prevention and care pathways. Although primary prevention remains a crucial step in the prevention of melanoma, the different surveys performed during the last 20\u2009years demonstrate that the use of sunscreen increases very slowly. Secondary prevention that includes skin screening and diagnostic measures may benefit from the development of digital tools. To improve adherence, patients need accurate, reliable information about their disease and the treatment options, and this type of content that can also be made available on digital tools. Shared decision\u2010making is a hallmark of a patient\u2010centered approach and requires health care providers who can communicate well to patients and their families, underscoring the pivotal role of health care professionals all through the patient journey. Health care providers have a crucial role in supporting patients through their journey in skin cancer. They will benefit from mobile apps and technologies that have been developed recently to address challenges in skin cancer prevention, detection and care, including those that are primarily directed to the patient. However, more peer\u2010reviewed studies are needed as well as regulations to ensure that apps are accurate, reliable, and up to date.<\/jats:p>","DOI":"10.1111\/jdv.19573","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:09:54Z","timestamp":1719392994000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multidisciplinary patient\u2010centered approach to the management of skin cancer"],"prefix":"10.1111","volume":"38","author":[{"given":"Brigitte","family":"Dr\u00e9no","sequence":"first","affiliation":[{"name":"Department of Dermatology and Skin Cancer and Unit of Cell and Gene Therapy Nantes University Hospital  Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mohr","sequence":"additional","affiliation":[{"name":"Department of Dermatology Elbe\u2010Kliniken Buxtehude  Buxtehude Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Sicard","sequence":"additional","affiliation":[{"name":"Pharmacie Principale SICARD  Ch\u00e2lons\u2010en\u2010Champagne France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Persson","sequence":"additional","affiliation":[{"name":"Centre for Rare Diseases \u2013 South Region Sk\u00e5ne University Hospital  Lund Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Barba\u00a0Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Asociaci\u00f3n Melanoma Espa\u00f1a  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-5122","authenticated-orcid":false,"given":"Mark\u00e9ta","family":"Saint\u00a0Aroman","sequence":"additional","affiliation":[{"name":"Pierre Fabre Dermo\u2010Cosm\u00e9tique Corporate Patient Centricity  Lavaur France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Alivon","sequence":"additional","affiliation":[{"name":"Pierre Fabre M\u00e9dicament  Boulogne\u2010Billancourt France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: a longitudinal analysis from the global burden of disease study, 1990\u20132017","volume":"2","author":"Urban K","year":"2021","journal-title":"JAAD Int"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"e_1_2_9_4_1","first-page":"490","article-title":"The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology","volume":"55","author":"Bickers DR","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_9_5_1","first-page":"183","article-title":"Prevalence and costs of skin cancer treatment in the US, 2002\u20102006 and 2007\u20102011","volume":"48","author":"Guy GP","year":"2015","journal-title":"Am J Prev Med"},{"key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040","volume":"158","author":"Arnold M","year":"2022","journal-title":"JAMA Dermatol"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas","volume":"379","author":"Nehal KS","year":"2018","journal-title":"N Engl J Med"},{"key":"e_1_2_9_8_1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3109\/0284186X.2013.765063","article-title":"Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study","volume":"52","author":"Mehnert A","year":"2013","journal-title":"Acta Oncol"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","article-title":"Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies","volume":"7","author":"Simard S","year":"2013","journal-title":"J Cancer Surviv"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12901","article-title":"Fear of cancer progression in patients with stage IA malignant melanoma","volume":"27","author":"Wagner T","year":"2018","journal-title":"Eur J Cancer Care"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejon.2015.07.006","article-title":"Khanna, supportive care needs and distress in patients with non\u2010melanoma skin cancer: nothing to worry about?","volume":"20","author":"Korner R","year":"2016","journal-title":"Eur J Oncol Nurs"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12811","article-title":"Unmet supportive care needs, health status and minimum costs in survivors of malignant melanoma","volume":"27","author":"Davies LM","year":"2018","journal-title":"Eur J Cancer Care"},{"key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/07347332.2019.1612973","article-title":"Prevalence and correlates of the supportive care needs of Italian early\u2010stage melanoma patients in follow\u2010up","volume":"37","author":"Miniotti M","year":"2019","journal-title":"J Psychosoc Oncol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(22)00242-2","article-title":"Management of common clinical problems experienced by survivors of cancer","volume":"399","author":"Emery J","year":"2022","journal-title":"Lancet"},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.canep.2010.03.006","article-title":"A nationwide population\u2010based skin cancer screening in Germany: proceedings of the first meeting of the international task force on skin cancer screening and prevention (September 24 and 25, 2009)","volume":"34","author":"Geller AC","year":"2010","journal-title":"Cancer Epidemiol"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaad.2010.11.016","article-title":"Systematic skin cancer screening in northern Germany","volume":"66","author":"Breitbart EW","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_9_17_1","first-page":"629","article-title":"Skin cancer screening in Germany. documenting melanoma incidence and mortality from 2008 to 2013","volume":"112","author":"Katalinic A","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/bjd.14758","article-title":"Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity","volume":"175","author":"Trautmann F","year":"2016","journal-title":"Br J Dermatol"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/cncr.29755","article-title":"Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig\u2010Holstein and Germany","volume":"122","author":"Stang A","year":"2016","journal-title":"Cancer"},{"key":"e_1_2_9_20_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bjd.20658","article-title":"Are patients benefiting from participation in the German skin cancer screening program? A large cohort study based on administrative data","volume":"186","author":"Datzmann T","year":"2022","journal-title":"Br J Dermatol"},{"key":"e_1_2_9_21_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112838","article-title":"Trend shifts in age\u2010specific incidence for in\u00a0situ and invasive cutaneous melanoma in Sweden","volume":"13","author":"Eriksson H","year":"2021","journal-title":"Cancer"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejon.2019.05.009","article-title":"Patient\u2010reported perceptions of care after the introduction of a new advanced cancer nursing role in Sweden","volume":"41","author":"Westman B","year":"2019","journal-title":"Eur J Oncol Nurs"},{"key":"e_1_2_9_23_1","unstructured":"Pharmacists and pharmacies. OECDiLibrary; 2022.https:\/\/www.oecd\u2010ilibrary.org\/sites\/d6227663\u2010en\/index.html?itemId=\/content\/component\/d6227663\u2010en#figure\u2010d1e13823"},{"key":"e_1_2_9_24_1","article-title":"Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes J","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/pcmr.12907","article-title":"The role of technology in melanoma screening and diagnosis","volume":"34","author":"Young AT","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"e_1_2_9_26_1","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1200\/JCO.2005.05.0864","article-title":"Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer","volume":"24","author":"Argenziano G","year":"2006","journal-title":"J Clin Oncol"},{"key":"e_1_2_9_27_1","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.3390\/cancers14235886","article-title":"Diagnostics using non\u2010invasive technologies in dermatological oncology","volume":"14","author":"Soglia S","year":"2022","journal-title":"Cancers (Basel)"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/DSS.0000000000003134","article-title":"Mobile applications in skin cancer detection: a descriptive analysis","volume":"47","author":"John AM","year":"2021","journal-title":"Dermatol Surg"},{"key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ijd.15132","article-title":"Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?","volume":"60","author":"Kong FW","year":"2021","journal-title":"Int J Dermatol"},{"key":"e_1_2_9_30_1","unstructured":"SunSmart global UV app helps protect you from the dangers of the sun and promotes public health. World health Organization2022."},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m127","article-title":"Algorithm based smartphone apps to assess risk of skin cancer in adults: systematic review of diagnostic accuracy studies","volume":"368","author":"Freeman K","year":"2020","journal-title":"BMJ"},{"key":"e_1_2_9_32_1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/bjd.20903","article-title":"Accuracy of commercially available smartphone applications for the detection of melanoma","volume":"186","author":"Sun MD","year":"2022","journal-title":"Br J Dermatol"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"S763","DOI":"10.1016\/j.annonc.2020.08.1263","article-title":"A digital companion for patients with BRAF\u2010mutant advanced melanoma treated with targeted therapies: TAVIE skin app","volume":"31","author":"Mohr P","year":"2020","journal-title":"Ann. Oncol."}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.19573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T09:12:00Z","timestamp":1719393120000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.19573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":32,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1111\/jdv.19573"],"URL":"https:\/\/doi.org\/10.1111\/jdv.19573","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"2023-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}